Eric Lefebvre, Chief Medical Officer at PLIANT THERAPEUTICS, INC. (PLRX), sold 5,000 shares at $25.05 ($125K) on 2022-10-25, disclosed to the SEC on 2022-10-27.
Open-market sale of $125k PLRX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PLRX | SELL | 2024-01-19 | $355K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $804K | — | Filing → |
| PLRX | SELL | 2023-04-03 | $596K | — | Filing → |